Nuveen’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.2M Sell
351,809
-17,470
-5% -$1.11M 0.01% 1048
2025
Q4
$23.5M Sell
369,279
-1,636
-0.4% -$102K 0.01% 1055
2025
Q3
$20.4M Buy
370,915
+63,416
+21% +$2.61M 0.01% 1138
2025
Q2
$10.2M Sell
307,499
-43,869
-12% -$1.53M ﹤0.01% 1498
2025
Q1
$14.1M Sell
351,368
-21,861
-6% -$1M ﹤0.01% 1343
2024
Q4
$17.6M Sell
373,229
-9,947
-3% -$517K 0.01% 1260
2024
Q3
$20.2M Buy
383,176
+28,035
+8% +$1.56M 0.01% 1190
2024
Q2
$19.2M Sell
355,141
-144,460
-29% -$8.72M 0.01% 1157
2024
Q1
$35M Buy
499,601
+156,000
+45% +$12.1M 0.01% 822
2023
Q4
$28.7M Sell
343,601
-26,023
-7% -$942K 0.01% 915
2023
Q3
$10.9M Buy
369,624
+2,462
+0.7% +$82K ﹤0.01% 1427
2023
Q2
$12M Buy
367,162
+22,253
+6% +$823K ﹤0.01% 1392
2023
Q1
$12.1M Sell
344,909
-14,697
-4% -$600K ﹤0.01% 1363
2022
Q4
$16.5M Sell
359,606
-2,747
-0.8% -$118K 0.01% 1171
2022
Q3
$17.6M Buy
362,353
+1,344
+0.4% +$64.7K 0.01% 1108
2022
Q2
$14.2M Buy
361,009
+102,426
+40% +$4.12M 0.01% 1283
2022
Q1
$9.2M Sell
258,583
-1,707
-0.7% -$60.7K ﹤0.01% 1697
2021
Q4
$9.51M Sell
260,290
-22,259
-8% -$859K ﹤0.01% 1727
2021
Q3
$9.57M Buy
282,549
+25,117
+10% +$739K ﹤0.01% 1812
2021
Q2
$5.09M Sell
257,432
-38,434
-13% -$902K ﹤0.01% 2237
2021
Q1
$6.88M Sell
295,866
-73,338
-20% -$1.57M ﹤0.01% 2001
2020
Q4
$7.67M Sell
369,204
-175,396
-32% -$3.21M ﹤0.01% 1863
2020
Q3
$11.8M Buy
544,600
+247,892
+84% +$5.8M ﹤0.01% 1414
2020
Q2
$6.99M Buy
296,708
+50,165
+20% +$941K ﹤0.01% 1711
2020
Q1
$2.91M Buy
246,543
+492
+0.2% +$6.28K ﹤0.01% 2007
2019
Q4
$2.61M Sell
246,051
-174,381
-41% -$1.79M ﹤0.01% 2317
2019
Q3
$4.79M Buy
420,432
+224,569
+115% +$2.82M ﹤0.01% 1978
2019
Q2
$2.2M Buy
+195,863
New +$1.89M ﹤0.01% 2388

Other funds holding CYTK